Nicholas Company Inc. lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 181,225 shares of the medical instruments supplier’s stock after acquiring an additional 220 shares during the quarter. Nicholas Company Inc. owned 0.08% of DENTSPLY SIRONA worth $11,750,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in XRAY. Commonwealth Bank of Australia grew its stake in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after acquiring an additional 260 shares during the period. Dupont Capital Management Corp bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $116,000. Korea Investment CORP grew its stake in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after acquiring an additional 1,251 shares during the period. Sphera Funds Management LTD. bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $162,000. Finally, Penserra Capital Management LLC grew its stake in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after acquiring an additional 240 shares during the period. Hedge funds and other institutional investors own 93.97% of the company’s stock.

A number of analysts have recently commented on XRAY shares. Goldman Sachs Group, Inc. (The) lowered shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target for the company. Finally, Credit Suisse Group reiterated an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $65.73.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Shares Bought by Nicholas Company Inc.” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/16/dentsply-sirona-inc-xray-shares-bought-by-nicholas-company-inc.html.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded up 2.10% during mid-day trading on Friday, reaching $59.34. 2,670,746 shares of the company traded hands. DENTSPLY SIRONA Inc. has a 52 week low of $52.54 and a 52 week high of $65.68. The firm’s market capitalization is $13.62 billion. The firm has a 50-day moving average price of $57.21 and a 200 day moving average price of $61.78.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. During the same period last year, the firm posted $0.76 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.